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INCREASED C-FOS EXPRESSION IN NODOSE GANGLION IN RATS 
WITH ELECTRICAL VAGUS NERVE STIMULATION
Abstract: Increased c-fos expression in nodose ganglion in rats with electrical vagus nerve 
stimulation
B a c k g r o u n d. Central nervous system receives information from the gut and modifies food 
intake mainly by vagus nerves. Some our data show that long — term electrical vagus nerve 
stimulation (VNS), which “mimics” satiety signal from gut, may cause reduction of body mass 
and decrease in food intake.
 O b j e c t i v e. The purpose of this study was to assess the effects of chronic vagal stimulation 
on neurons in the nodose ganglions of vagus nerves, analyzed by c-Fos expression and image 
analysis. 
 M e t h o d s. Male Wistar rats (n = 24) were implanted with microstimulator (MS) and kept 
during the whole study (3 months) on high calorie diet. Sub-diaphragmatic left vagal nerve was 
stimulated by electrical rectangular pulses duration 10 ms, amplitude 200 mV, frequency 0.05 Hz 
generated by MS. Twelve rats (6 — control and 6 — MS implanted) were used for 3-week and 
3-month experiments respectively. At the end of experiments the nodose ganglions of both vagus 
nerves (left and right) were taken, formalin fixed and paraffin-embedded specimens were made. 
The nodose ganglions neurons were identified by immunochemistry (PGP 9.5 as a marker) and 
the percentage of c-Fos positive neurons (anti c-Fos as a marker) were evaluated. 
 R e s u l t s. Assessment of c-Fos positive neurons in nodose ganglia of vagal nerve showed 
significant increase in percentage of positive cells in the left nodose ganglion (4.19%) and non 
significant in the right nodose ganglion (2.64 %) compared to control (1.44%) in 3-week experiment. 
Data obtained from 3-month experiment were similar: (4.97%; 2.66% and 1.68%) for left, right 
and control respectively. In both experiments number of c-Fos positive neurons was higher in left 
vagal ganglion compared to the right ganglion and control. There were no significant differences 
between 3-week and 3-month experimental groups.
 C o n c l u s i o n s. Increase in c-Fos expression in left nodose ganglion neurons confirms 
the afferent transmission of the signal (generated by MS) from periphery to the brain by the vagal 
nerves.
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INTRODUCTION
Vagus nerves provide the major neuroanatomical link between gastrointestinal 
sites and the brain. Central nervous system (CNS) controls feeding behavior 
and metabolism after receiving information from the gut, modifying food intake. 
Gastric mechanoreceptors and jejunal chemoreceptors activated by food inge-
stion evoke electrical impulses transmitted by afferent fibers of vagus nerves 
into the CNS sites, to suppress feeding [1, 2, 3].
The left and right vagus nerves are formed by converging afferent and effe-
rent rootlets as they leave the cranium through the jugular foramen. Outside 
the cranium lie the proximal jugular and the slightly more distal nodose gan-
glions, which harbor the neuronal cell bodies of the sensory neurons [3, 4]. 
Nodose ganglion of adult male or female rats contains about 6000 neurons. 
The size of nodose neurons ranges from 15 to 50 µm in diameter [5].
Several markers for metabolic activity have been demonstrated in primary 
sensory neurons of vagus nerves — cytochrome oxidase, c-Fos and c-Jun pro-
teins. The c-fos and c-jun belong to the family of the immediate early genes. 
They are expressed rapidly in the nodose ganglions and in the CNS after va-
rious forms of stimulation and their protein products c-Fos and c-Jun partici-
pate as “third messengers” in the regulation of neurotransmitter and peptide 
expression in those neurological structures [6]. Increase in c-Fos expression is 
now widely accepted as a marker of neuronal activity.
Central terminals of primary vagal afferents are mainly found in the nuc-
leus tractus solitarius (NTS) and the area postrema, fewer in the dorsal motor 
nucleus of the vagus and in the trigeminal islands [3, 4, 7]. Afferent vagal fibres 
convey sensory information from the upper gastrointestinal tract to the CNS. 
In vagus nerve, afferent fibres outnumber efferent fibres by 10 to 1 [7]. Consi-
dering this, peripheral vagus nerve stimulation could be sufficiently effective to 
influence the central nervous system neurons activity. 
Vagus nerve stimulation (VNS) has been introduced in therapy of some neu-
rological disorders, as epilepsy [8], depression [9], various anxiety disorders [9], 
Alzheimer’s disease, migraines [10], fibromyalgia [11] and tinnitus [12]. It has 
also been reported, that stimulation of the vagus nerve influences cytokine 
production and improves survival in experimental sepsis, hemorrhagic shock 
and ischemia-reperfusion injury models [13]. Unexpectedly, in some patients 
treated with VNS therapy, weight decrease and reduction in food intake were 
observed. This fact has inspired researchers to investigate the mechanisms 
of weight loss after vagus nerve stimulation and to introduce VNS as a new 
method for obesity treatment [14, 15].
We previously showed that both short- and long-term vagus stimulation 
affect food intake and decrease body weight in rats [16, 17, 18, 19]. Moreover, 
Bugajski et al. [20] reported a decrease in meal size, a body weight reduction 
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and a decrease in epididymal fat pad weight in obese rats. Ziomber et al. [21] 
presented, that modulation of left vagus nerve by solenoid placed in rats with 
magnetic field exposure leads to decrease in body weight gain in growing ani-
mals. We hypothesized that peripheral electrical vagus nerve stimulation can 
“mimic” satiety signals from the gut to the CNS, leading to body mass reduction 
and to decrease in food consumption. To confirm our theory we assessed in 
this study the morphological properties and c-Fos immunoreactivity in neurons 
of nodose ganglion of vagus nerve after chronic left vagus nerve stimulation. We 
have stimulated left vagus nerve peripherally (the sub-diaphragmatic part), to 
limit possible side effects of VNS on the heart or the lungs, as the right vagus 
feeds those organs. Nevertheless, we examined both — left and right nodose 
ganglion neurons. 
MATERIALS AND METHODS
Male Wistar rats (n = 24) weighing at the beginning of the study 200  ±  25 g 
were used. The animals were fed the high fat diet to induce obesity (DIO) (Bento 
Kronen Products, Belgium) during whole experiment. The caloric distribution 
of the DIO was: protein 29.5%, fat 45.6%, carbohydrates 24.9%, and metabo-
lizable energy was 4.34 kcal/g. All animals were housed in the same optimal 
conditions of the lifestyle with food and water ad libitum and at 23  ±  2°C tem-
perature on a 12 : 12-hour dark/light cycle. The Jagiellonian University Bioe-
thical Committee approved the care and use of the animals. 
After about 2 weeks of adaptation to new environmental conditions and fat 
diet rats were starved for 12 hours and operated in general anesthesia indu-
ced with sodium pentobarbital given intraperitoneally (Vetbutal, 0.25 mg/kg, 
i.p., Biowet, Puławy, Poland). The rats were randomly divided into two groups: 
1. rats with active microstimulator (MS) connected by electrodes with the left 
vagal nerve (MS group, n = 12), 2. animals with inactive MS without electrodes 
on the vagal nerve (control group, n = 12). The MS for chronic vagal stimulation 
(Institute of Electron Technology, Cracow, Poland) was placed into the subcu-
taneous pocket and the ends of the MS silver electrodes were wrapped around 
the subdiaphragmatic left vagal nerve; cathode and anode were positioned at 
0.5 cm distance. The parameters of the impulses generated by MS were: uni-
polar rectangular pulses duration — 10 ms, amplitude — 200 mV, frequency 
— 0.05 Hz. The parameters of MS stimulation were set, based on our previous 
studies [16, 17]. In the second group of animals inactive MS was implanted 
and laparotomy was performed (control group).
After 3 weeks of MS stimulation, randomly chosen rats from MS group 
(n = 6) and control group (n = 6) were euthanized and nodose ganglions (left 
and right) were taken for analysis. The other rats were stimulated until the 
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end of the third month, then they were euthanized and further analyses were 
made. Nodose ganglions were formalin fixed, paraffin-embedded block were 
made, and 5 μm slices were cut and mounted on silanized slides for further 
stainings. Firstly, specimens were hematoxylin — eosin stained for routine hi-
stology. For immunostaining heat induced antigen retrieval was carried out 
to unmask antigen determinants (20 min. in 95°C Target Retrival Solution 
— DAKO). Nodose ganglion neurons were identified using primary polyclonal 
antibodies (rabbit PGP 9.5 — DAKO; 1 : 200, 24 h at 4°C) with LSAB2 (DAKO) 
visualization system using diamino-benzidine — DAB — (DAKO) as a chromo-
gen, according to protocol provided by manufacturer. c-Fos positive neurons 
were indentified with immunofluorescence (IF) method. After incubation with 
primary rabbit polyclonal anti-c-Fos antibody with 0.5% Triton X-100 (anti 
c-Fos, Santa Cruz Biotechnology; 1 : 100, 24 h at 4°C), secondary biotynylated 
antibody goat anti-rabbit (Jackson ImmunoResearch Laboratories, 1 : 800) was 
added for 2 h at room temperature. After rinsing in phosphate buffer anti-goat 
antibody conjugated with Cy3 (Jackson ImmunoResearch Laboratories, Inc., 
1 : 800) was applied for 1 h. Slides were mounted with Fluorescent Mounting 
Medium (DAKO Cytomation) and analysis of specimens were performed under 
fluorescence JENAMED2 (Zeiss) microscope with wave length 570 nm.
The area of PGP 9.5 positive cells was assessed by image analysis (Multi-
scan 18.03, CSS) in light microscopy. In each specimen at least 200 neurons 
were analyzed. Cells positive for c-Fos staining were counted and data were 
expressed as a percentage of total neurons in nodose ganglion in IF stained 
specimens. Data are expressed as mean and standard deviation (SD). Results 
were analyzed by one-way analysis of variance (ANOVA), followed by post-hoc 
LSD test with STATISTICA 9.0 software package (StatSoft, Tulsa). Statistical 
significance was set at p < 0.05.
RESULTS
Chronic vagus nerve stimulation increased percentage of c-Fos positive neurons 
in the left nodose ganglions in both, 3-weeks and 3-months stimulated rats. 
Assessment of c-Fos positive cells showed significant (p = 0.00006) increase in 
percentage of those neurons in the left nodose ganglion (4.19  ±  2.26%) compa-
red to control (1.44  ±  1.18%) in 3-weeks experiment. Interestingly, there was 
also an increase in c-For neurons in the right nodose ganglion (2.64  ±  1.98%) 
compared to control (1.50  ±  1.53%, p = 0.054) (Fig. 1).
Data obtained from 3-month experiment were similar: 4.97  ±  1.54%; for 
left VNS and 1.68  ±  1.51% for left control nodose ganglion (p = 0.0001), and 
(2.66  ±  1.88% versus 1.45  ±  1.57%, p = 0.024) for the right VNS and control 
respectively (Fig. 2).
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Fig. 1. c-Fos positive neurons percentage in the rats after 3 weeks of electrical left vagus nerve 
stimulation (VNS) and control in the left and right nodose ganglions. Data expressed as mean 
± 0.95 confidence interval
Ryc. 1. Odsetek neuronów c-Fos pozytywnych w lewym i prawym zwoju guzowatym szczura  
po 3 tygodniach elektrycznej stymulacji nerwu błędnego oraz w grupie kontrolnej.  
Dane przedstawiono jako średnią wraz z przedziałem ufności 0,95
Fig. 2. c-Fos positive neurons percentage in the rats after 3 months of electrical left vagus 
nerve stimulation (VNS) and control in the left and right nodose ganglions. Data expressed  
as mean ± 0.95 confidence interval
Ryc. 2. Odsetek neuronów c-Fos pozytywnych w lewym i prawym zwoju guzowatym szczura  
po 3 miesiącach elektrycznej stymulacji nerwu błędnego oraz w grupie kontrolnej.  
Dane przedstawiono jako średnią wraz z przedziałem ufności 0,95
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Fig. 3. Morphometrical assessment of the left and right nodose ganglion neurons  
in the rats after 3 weeks of electrical left vagus nerve stimulation (VNS) and control groups.  
Data expressed as mean ± 0.95 confidence interval
Ryc. 3. Analiza morfometryczna neuronów w lewym i prawym zwoju guzowatym szczura  
po 3 tygodniach elektrycznej stymulacji nerwu błędnego oraz w grupie kontrolnej.  
Dane przedstawiono jako średnią wraz z przedziałem ufności 0,95
Fig. 4. Morphometrical assessment of the left and right nodose ganglion neurons  
in the rats after 3 months of electrical left vagus nerve stimulation (VNS) and control groups. 
Data expressed as mean ± 0.95 confidence interval
Ryc. 4. Analiza morfometryczna neuronów w lewym i prawym zwoju guzowatym szczura  
po 3 miesiącach elektrycznej stymulacji nerwu błędnego oraz w grupie kontrolnej.  
Dane przedstawiono jako średnią wraz z przedziałem ufności 0,95
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There were no significant differences in c-Fos count between 3 weeks and 
3 months stimulated animals, respectively. In both sets of experiments c-Fos 
positive neurons percentage did not differ between left and right nodose gan-
glions in controls group.
Image analysis of nodose ganglion neurons showed significant (p = 0.001) 
increase in mean cell area in rats with VNS in the left nodose ganglion 
(535.2  ±  172.8 μm2) compared to control value (425.7  ±  163.6 μm2) after 3 weeks 
of stimulation. Surprisingly, there was also a small increase in right nodose gan-
glion area (509.1  ±  198.8 μm2 versus control 446.9  ±  171.8 μm2)  after 3 weeks 
of stimulation, but not significant (p > 0.05) (Fig. 3).
Data obtained from 3-month experiment were similar: an increase in mean 
neurons area in rats with VNS in the left nodose ganglion as well as in the 
right were present: for the left nodose ganglion neurons (523.2  ±  168.9 μm2 for 
left VNS versus 448.1  ±  172.2 μm2 for control, significant; p = 0.0001) and for 
the right (509.1  ±  198.7 μm2 for right VNS versus 470.5  ±  180.8 μm2 for control 
respectively, non significant; p > 0.05) (Fig. 4).
There were no significant differences between 3-weeks and 3-months exper-
imental groups. In both experimental groups neuron area values were slightly 
higher, but not significantly, for the right vagal nodose ganglion neurons in 
controls compared to the left (about 5%). Nodose ganglion of control rat in 
routine hematoxylin-eosin staining and PGP 9.5 positively — stained cells are 
shown in Figure 5.
DISCUSSION
The cell bodies of vagal visceral afferents are contained within the nodose 
ganglia. Central projections of these neurons enter the brain stem and make 
synaptic connection with second order neurons that distribute visceral infor-
mation throughout central neuronal structures [1, 7]. The branching pattern of 
vagus nerve in the abdomen has been best characterized in the rat. The ven-
tral or anterior trunk, which is contiguous with the left cervical vagus, bran-
ches into the common hepatic, ventral gastric and ventral (or accessory) celiac 
branches. The common hepatic branch divides typically at about one third the 
distance between diaphragm and gastric cardia. Using electron microscopy on 
cross sectioned nerves, and supra- vs. infra-nodose cervical, thoracic, or ab-
dominal vagotomies, the proportion of myelinated and unmyelinated axons as 
well as afferent, efferent and adventitial axons have been estimated. In the rat 
there are about 11,000 nerve fibers in each of the sub diaphragmatic trunks, 
of which about 8000 are afferent and 3000 efferent. Less than 1% of all fi-
bers are myelinated, and the average size of the unmyelinated fibers is about 
0.8 mm, with some axons as thin as 0.1 mm [4, 22]. As we desired to replace 
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A
Fig. 5. Nodose ganglion of the control rat. (A) Hematoxylin-eosin staining,  
neurons stained pink. Magnification 200 ×. (B) PGP9.5/DAB staining,  
nodose ganglion neurons stained brown. Magnification 200 ×
Ryc. 5. Zwój guzowaty szczura z grupy kontrolnej. (A) Barwienie hematoksylina-eozyna.  
Neurony wybarwione na różowo. Powiększenie 200 ×. (B) Barwienie PGP9.5/DAB.  
Neurony wybarwione na brązowo. Powiększenie 200 ×
B
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the physiological satiety input from the gut into the CNS by VNS, such sub-
diaphragmatic stimulation of the left vagus nerve has strong anatomical and 
physiological background. 
We use VNS in rats as a study method of obesity mechanisms, firstly — we 
have to establish the morphological criterion of VNS to be sufficiently effective, 
and secondly — to prove, that VNS, even after few weeks of stimulation still 
exerts its effects on vagal afferents neurons. In this study we have chosen 
3-week and 3-month periods, as we do not carry the VNS longer.
In current study we examined effects of the left vagus nerve stimulation on 
nodose ganglion neurons. When the left and right vagal trunks feed different 
parts of the gastrointestinal tract and contribution of both is important, the 
decision, which one of trunks should be stimulated, remains controversial. 
Previous works from our laboratory [16, 17] demonstrated that bilateral VNS 
seems to be more effective than unilateral stimulation, but the others proved 
that unilateral stimulation could be effective as well. To limit possible side 
effects on the heart or the lungs, we decided to apply a chronic VNS by mic-
rostimulator placed on the left vagus nerve. Electrodes were put close to the 
gastro-esophageal junction to stimulate the small unmyelinated C fibres and 
to avoid stimulation of fibres that join the trunk from the heart and lungs, as 
discussed by Val-Laillet [23]. We used constant voltage microstimulator im-
planted for at least 3 months, and set up higher frequency of stimulation simi-
lar to our previous experiments.
Assessment of c-Fos expression as a marker of neural activity offers several 
advantages. c-Fos is a delayed marker of brain activation. The neuronal pro-
cess that mediates neuronal activity and behavior at the time of stimulation 
may also initiate the slower processes of immediate-early gene activation and 
protein synthesis. Activation of the c-Fos gene by a sensory stimulus results in 
c-Fos protein synthesis within 1 h [24]. Because c-Fos is visualized about 1 h 
after stimulation, the presence of c-Fos in stimulated neural cells will be still 
detectable, even the stimulus were withdrawn. The pattern of c-Fos expression 
in the nodose ganglion provides cellular resolution of neural activity that can 
be quantified by counting the number of labeled cells [25]. The degree of c-Fos 
expression can then be even correlated with stimulus magnitude. Finally, c-Fos 
assessment allows mapping of neuronal populations activated by a stimulus. 
The central processing of visceral sensation is mediated by many nuclei throu-
ghout the brain. Because many sections can be processed for c-Fos, activity 
in multiple brain regions of the same animal can be visualized for the analysis 
of a distributed network. Moreover, the patterns of c-Fos expression can be 
interpreted against a large database of c-Fos references. 
First results on c-Fos after vagus nerve stimulation were disappointing 
— the c-Fos were not found in the nodose ganglion following either electrical 
stimulation or deafferentation of the cervical vagus nerve [26]. Later studies 
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showed that c-Fos has a low basal level of expression in the nodose ganglion 
but is greatly increased by crush or axotomy of the cervical vagus nerve. Cur-
rently, it is well established that c-Fos expressed neurons are present in no-
dose ganglia after variety of stimuli [27–36].
The amount of c-Fos positive, non-stimulated neurons in nodose ganglion 
do not exceed about 1–2% of cells. Our results are consistent with those data. 
We have found c-Fos neurons count to be less than 2% in control groups, both 
in the left and right nodose ganglions. However, after VNS almost four-fold 
increase in c-Fos positive cells was observed.
The results of our study indicate that VNS can lead to immunohistochemi-
cal as well as morphological changes of nodose ganglia neurons. It is important 
to mention, that morphological changes in the left, and partially in the right 
nodose neurons were noticed. There was a major increase in the area of neu-
rons in VNS animals in the left nodose ganglion. The increase in size of neu-
rons — “neuronal hypertrophy” — could be explained as a mode of adaptation 
to the increased activity of their targeted tissue, as a structural response to the 
functional overload imposed by VNS. Similar changes have been mentioned by 
Kosta in nodose ganglion neurons after intensive exercises in rats. The physical 
exercise in her study did not exert any influence on either ganglion size or total 
number of neurons, but the mean perikaryal volume of neurons significantly 
increased in trained animals [37]. Authors have speculated that since the no-
dose ganglia neurons showed extremely high potential for neurogenesis [38], 
so there is a small possibility that exercise causes neurogenesis in rat nodose 
ganglions. Since we reported similar observation of nodose ganglions neurons, 
further investigation with indicators of cell proliferation would be extremely 
helpful to obtain decisive results.
The sensory cells of the nodose and jugular ganglia of the rat have been 
also quantitatively evaluated in longitudinal paraffin sections obtained from 
rats after neonatal capsaicin treatment by Carobi [39]. According to this report, 
the right vagal ganglions contain significantly more neurons than the left one, 
particularly neurons with somata having sectioned areas 200–400 µm2 and 
longest diameters of 15–25 µm. It is consistent with our data, as we showed 
an increase in the mean right nodose ganglion neurons area compared to the 
left one. Neonatal capsaicin treatment reduced the number of neurons in both 
the left and right ganglia to about 30% of control values and destroyed neurons 
with sectioned areas of 100–600 µm2 and longest diameters of 15–35 µm, but 
had no statistically significant effects on larger neurons. It is possible, that VNS 
in our model somehow influenced smaller neurons, or just decreased PGP 9.5 
expression, leading to decrease in the cell area.
Vagal nerve stimulation caused significant changes in the left nodose gan-
glion (which were largely expected), but, surprisingly, some changes in c-Fos 
neuron count and the cell area of the right nodose ganglion cells were also 
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present. It is difficult to clarify such observation. It has been reported that in 
some species, including rats, thoracic and abdominal communicating branches 
between the left and right trunks exist, with afferent and/or efferent axons 
from one side crossing over to the other side [22, 40]. However, in the rat, 
there is little evidence from retrograde experiments for crossing efferent axons, 
but as many as 20% of afferent axons may cross at the thoracic level [41]. In 
the ferret an abdominal communicating branch has been characterized, with 
both efferent and afferent axons crossing sides [40]. Having been given these 
facts, there is still a possibility which cannot be excluded that VNS in current 
model evoked weak response in the right nodose ganglion. We can also specu-
late, whether VNS by some efferent mechanisms may induce cellular response, 
which activates vagal afferents, for example by gastric mast cells [19]. That 
phenomenon needs to be further examined.
CONCLUSIONS
Electrical vagus nerve stimulation with microstimulator placed on the left vagal 
nerve causes changes in neurons area and c-Fos expression in nodose gan-
glions, mainly in the left, but also in the right nodose ganglion. Those changes 
observed in both — left and right vagal ganglions after VNS are present  during 
the whole three-month experiment. Increase in c-Fos expression in nodose 
ganglion neurons confirms the afferent transmission of the signal (generated by 
MS) from periphery to the brain by the vagus nerves, and allows implementing 
the VNS technique as a new, effective method in obesity mechanisms research 
and management.
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STYMULACJA NERWU BŁĘDNEGO ZWIĘKSZA EKSPRESJĘ C-FOS 
W ZWOJACH GUZOWATYCH NERWU BŁĘDNEGO SZCZURA
S t r e s z c z e n i e
Centralny układ nerwowy otrzymuje informacje z przewodu pokarmowego oraz dostosowuje po-
bieranie pokarmu głównie dzięki informacjom docierającym za pośrednictwem nerwów błędnych. 
Nasze dotychczasowe badania wykazały, że przewlekła elektryczna stymulacja nerwu błędnego 
imitująca sygnały sytości wysyłane z przewodu pokarmowego powoduje spadek masy ciała oraz 
zmniejszone pobieranie pokarmu u szczurów.
Celem przeprowadzonych doświadczeń było zbadanie wpływu przewlekłej stymulacji nerwu 
błędnego na neurony zwojów guzowatych nerwu błędnego szczura oceniane poprzez analizę eks-
presji białka c-Fos oraz metodami morfometrycznymi. 
Szczurom rasy Wistar (n = 24) wszczepiono mikrostymulatory (MS) oraz karmiono dietą wyso-
kokaloryczną przez 3 miesiące. Lewy nerw błędny stymulowano elektrycznie (impulsy prostokątne, 
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czas trwania 10 ms, amplituda 200 mV, częstotliwość 0,05 Hz). 12 szczurów (6 — kontrola oraz 
6 — z MS) badano odpowiednio po 3 tygodniach oraz po 3 miesiącach. Pobierano lewy i prawy 
zwój guzowaty nerwu błędnego, utrwalano w formalinie i wykonywano preparaty techniką parafi-
nową. Neurony identyfikowano metodą immunohistochemiczną (PGP 9,5 jako marker) oraz liczono 
odsetek neuronów wykazujących pozytywny odczyn z przeciwciałem anty c-Fos.
Po 3 tygodniach stymulacji odsetek neuronów c-Fos pozytywnych w zwojach guzowatych był 
podwyższony znamiennie w lewym (4,19%) oraz słabo w prawym zwoju (2,64%) w odniesieniu do 
kontroli (1,44%). Podobne dane uzyskano po 3 miesiącach stymulacji: 4,97%; 2,66% i 1,68%, 
odpowiednio dla zwoju lewego i prawego po stymulacji oraz kontroli. Nie stwierdzono różnic po-
między odpowiednimi grupami po 3-tygodniowej i 3-miesięcznej stymulacji.
Podwyższony odsetek neuronów c-Fos pozytywnych w lewym zwoju guzowatym nerwu błęd-
nego potwierdza aferentną transmisję sygnału generowanego przez mikrostymulator z obwodu do 
mózgu drogą nerwu błędnego.
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